SHANGHAI, Sept. 4, 2020 /PRNewswire/ -- On August 25, 111, Inc. ("111" or the "Company")
(Nasdaq: YI), a company dedicated to digitally connecting patients
with drugs and healthcare services in China, and Guangzhou Baiyunshan Pharmaceutical
Sales Co., Ltd. ("Baiyunshan Pharmaceutical Sales"), an affiliate
of Guangzhou Pharmaceuticals Corporation, signed a strategic
cooperation agreement in Shanghai.
Under the agreement, 111 will be the first Internet-based
omni-channel business partner of Baiyunshan Pharmaceutical Sales.
Both parties will deepen their cooperation in digital medicine
innovation to drive the penetration of its expansive portfolio of
medical health products into wider online and offline markets
through integration of 111's smart supply chain. The partnership
also extends to cover the likes of big data, digital marketing,
brand co-building and offering of direct services to patients,
making concerted efforts to create a quality value chain.
Internet-based medical and health companies have played an
active role in the fight against the global COVID-19 pandemic
crisis this year, reflecting their value and contributions with
recognition from the communities and nations.
Pei Zejian, Vice Director, Great South TCM, Guangzhou
Pharmaceutical Holdings Limited, Secretary of the Party Committee
and Chairman of Guangzhou Baiyunshan Pharmaceutical Sales Co.,
Ltd., said the pandemic further accelerated the development of
digital healthcare industry and Internet is becoming an
increasingly important channel to pharmaceutical companies.
Internet not only helps to improve the accessibility of medicines,
but also make it convenient for patients to receive medical
services. As leader in the industry, 111 has a unique business
model that enables and helps pharmaceutical companies to transform
and thrive in the Internet era. With a strong basis for
cooperation, Baiyunshan Pharmaceutical Sales and 111 are confident
that by leveraging and combining their strength, the partnership
will benefit more patients in the future.
Dr. Gang Yu, Co-Founder and
Executive Chairman of 111 Inc.,
said that when the medical and health industry ushered in the tide
of Internet, Baiyunshan Pharmaceutical Sales always embraces change
with an open and innovative mind. In years of cooperation, 111
Inc. and Baiyunshan Pharmaceutical Sales have established strategic
partnership. This tight relationship will further expand the depth
and breadth of cooperation between the two companies. Driven by
111's digital technology, and supported by the strategy of
omni-channel drug commercialization
and online/offline integration, the high-quality products of
Baiyunshan Pharmaceutical Sales can reach more customers.
About Guangzhou Baiyunshan Pharmaceutical Sales Co., Ltd
and Company
Baiyunshan Pharmaceutical Sales Co., Ltd. is an all-in-one
marketing platform of Guangzhou Pharmaceuticals Corporation, which
has so far integrated marketing businesses of four companies,
namely, Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.,
Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd., Guangzhou
Baiyunshan Jingxiutang Pharmaceutical Co., Ltd. and Guangzhou
Baiyunshan Mingxing Pharmaceutical Co., Ltd. The company is
operating business of branded products under different trademarks,
covering over 300 types of medicines including anti-ED drugs,
antibiotics, Chinese patent medicines, and others based on pure
traditional Chinese medicines, among others.
About 111, Inc.
111, Inc. (NASDAQ: YI) ("111" or the "Company") is a company
dedicated to digitally connecting patients with drugs and
healthcare services in China. The
Company provides hundreds of millions of consumers with better
access to pharmaceutical products and medical services directly
through its online retail pharmacy and indirectly through its
offline pharmacy network. 111 also offers online medical services
through its internet hospital, 1 Clinic, which provides consumers
with cost-effective and convenient online consultation and
electronic prescription services. In addition to providing direct
services to consumers through its online retail pharmacy, 111 also
enables offline pharmacies to better serve their
customers. The Company's online wholesale pharmacy, 1 Drug
Mall, serves as a one-stop shop for pharmacies to source a vast
selection of pharmaceutical products. The Company's New Retail
platform, by integrating the front and back ends of the
pharmaceutical supply chain, has formed a smart supply chain, which
transforms the flow of pharmaceutical products to pharmacies and
modernizes how they serve their customers.
For more information on 111, please visit:
http://ir.111.com.cn/.
For more information, please contact:
111, Inc.
Investor Relations
Email: ir@111.com.cn
111, Inc.
Media Relations
Email: press@111.com.cn
Phone: +86-021-2053 6666 (China)
GCM Strategic Communications
IR Counsel
Email: 111.ir@gcm.international
View original
content:http://www.prnewswire.com/news-releases/111-inc-partners-with-baiyunshan-pharmaceutical-sales-in-digital-medicine-innovation-301124407.html
SOURCE 111, Inc.